MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity
Shan Zhou, Xian Ling, Jielin Zhu, Ye Liang, Qijian Feng, Chao Xie, Jiemei Li, Qiyan Chen, Shuangqin Chen, Jinhua Miao, Mengyao Zhang, Zhiru Li, Weiwei Shen, Xiaolong Li, Qinyu Wu, Xiaoxu Wang, Ruiyuan Liu, Cheng Wang, Fan Fan Hou, Yaozhong Kong, Youhua Liu, Lili Zhou
Abstract
MAGL is a potential diagnostic marker for kidney function decline, and also serves as a new therapeutic target for renal fibrosis through ameliorating lipotoxicity.
Topics & Concepts
Monoacylglycerol lipaseFibrosisKidneyEndocannabinoid systemMedicineRenal functionFoam cellPharmacologyChemistryInternal medicineReceptorCholesterolLipoproteinCannabis and Cannabinoid ResearchDiet, Metabolism, and DiseasePancreatic function and diabetes